A detailed history of Kapitalo Investimentos Ltda transactions in Abb Vie Inc. stock. As of the latest transaction made, Kapitalo Investimentos Ltda holds 1,312 shares of ABBV stock, worth $223,919. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,312
Holding current value
$223,919
% of portfolio
0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $214,958 - $261,520
1,312 New
1,312 $259 Million
Q4 2023

Mar 29, 2024

SELL
$137.6 - $154.97 $93,017 - $104,759
-676 Closed
0 $0
Q3 2023

Mar 29, 2024

SELL
$133.59 - $154.65 $41,412 - $47,941
-310 Reduced 31.44%
676 $101 Million
Q2 2023

Mar 29, 2024

BUY
$132.51 - $164.9 $130,654 - $162,591
986 New
986 $133 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.